XML 30 R17.htm IDEA: XBRL DOCUMENT
v3.23.1

REVENUES (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2023
REVENUES |
Schedule of Company's Disaggregation of Revenues | The following table summarizes the Company’s disaggregation of revenues:
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Three Months Ended March 31, | ​ | ​
(U.S. dollars in thousands) |  | 2023 |  | 2022 | ​ | ​
Pfizer | ​ | $ | 2,266 | ​ | $ | 3,356 | ​ | ​
Brazil | ​ | $ | 2,800 | ​ | $ | 5,454 | ​ | ​
Chiesi | ​ | $ | — | ​ | $ | 218 | ​ | ​
Total revenues from selling goods | ​ | $ | 5,066 | ​ | $ | 9,028 | ​ | ​
Revenues from license and R&D services | ​ | $ | 4,522 | ​ | $ | 7,057 | ​ | ​

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RevenueRecognitionAndDeferredRevenueAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration